ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
AbbVie, nearing the end of Humira's historic run, scoops up a struggling Allergan for $63B
June 28, 2019It's not the first time Allergan has brought in a pharma suitor for a takeout. Previously, the company was set to merge with Pfizer in a $160 billion tax inversion, but the companies called it off in the wake of new Treasury rules. That deal valued Allerg
Pharma Sources Insight January 2025
